Peptide Law Database
Comprehensive guide to peptide regulations by country. Select a jurisdiction below to view detailed legal information, import rules, and regulatory frameworks.
North America
United States
RestrictedPeptides are restricted in the United States under a two-track system enforced by the Food and Drug Administration (FDA): peptides with FDA-approved drug...
Canada
RestrictedPeptides in Canada are restricted rather than freely available: Health Canada regulates all peptide drugs as prescription products under its drug authorization...
Mexico
RestrictedPeptides are restricted in Mexico rather than freely sold over the counter: most research/regenerative peptides (e.g., BPC-157, TB-500) are not individually...
Costa Rica
RestrictedPeptides in Costa Rica are restricted rather than outright banned as a class: the Ministerio de Salud (Ministry of Health) requires every medicine to hold a...
Europe
European Union
RestrictedPeptides are restricted in the European Union rather than freely legal or outright banned as a class: some peptide drugs (semaglutide, tirzepatide,...
United Kingdom
Gray AreaPeptides occupy a split legal status in the United Kingdom: most research peptides (e.g. BPC-157, TB-500) are unscheduled and legal to possess for research...
Germany
RestrictedPeptides are restricted in Germany, with legal treatment depending entirely on the specific compound and its intended use. Approved therapeutic peptides such...
Netherlands
Gray AreaPeptides in the Netherlands are gray-area substances rather than clearly legal or clearly illegal: the Geneesmiddelenwet (Medicines Act) requires any product...
France
Gray AreaPeptides in France fall into two very different legal buckets, so there is no single blanket verdict. Approved peptide drugs (semaglutide/Ozempic,...
Spain
Gray AreaPeptides in Spain fall into a gray/restricted zone: Spain has no separate 'peptide law,' so their legality depends entirely on whether the specific molecule...
Italy
RestrictedPeptides are restricted in Italy under a two-track system rather than being broadly legal or broadly banned. Medicinal peptides (e.g., semaglutide-class GLP-1...
Poland
RestrictedPeptides are restricted in Poland under the general Pharmaceutical Law rather than a peptide-specific statute: any substance intended to treat, prevent, or...
Switzerland
RestrictedPeptides are restricted in Switzerland: any substance intended to produce a pharmacological, immunological, or metabolic effect in humans is legally classified...
Greece
RestrictedPeptides are restricted in Greece rather than freely legal or blanket-banned. The Hellenic Medicines Organization (EOF), following EU/EMA rules, treats GLP-1...
Portugal
RestrictedPeptides in Portugal are restricted rather than freely legal: the national medicines statute requires that any product presented for a therapeutic purpose...
Belgium
Gray AreaPeptides are not illegal as a class in Belgium, but most popular research/compounding peptides (BPC-157, TB-500, ipamorelin, etc.) have no marketing...
Sweden
Gray AreaPeptides in Sweden are legal only when they are approved, prescription-only medicinal products supplied through a pharmacy; unapproved 'research' peptides fall...
Ireland
Gray AreaPeptides are in a legal gray zone in Ireland: research peptides such as BPC-157 and TB-500 have no marketing authorisation from the Health Products Regulatory...
Russia
Gray AreaPeptides in Russia fall into two very different legal buckets: pharmaceutical-grade peptide drugs that have gone through State Registration (like semaglutide...
Asia-Pacific
Australia
RestrictedPeptides are restricted, not freely legal, in Australia. The Therapeutic Goods Administration (TGA) regulates any product intended for therapeutic use under...
New Zealand
RestrictedPeptides are restricted in New Zealand: therapeutic peptides fall under the Medicines Act 1981 framework administered by Medsafe, and products like BPC-157 or...
Japan
RestrictedPeptides are restricted in Japan under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (the PMD Act,...
China
RestrictedPeptides are restricted in China under the general framework of the Pharmaceutical Administration Law, which requires any product marketed, sold, or...
India
RestrictedPeptides are not treated in India as a single unified legal category: unapproved research peptides like BPC-157 and TB-500 fall outside any approved drug list...
Thailand
Gray AreaPeptides are legal in Thailand only in a split, compound-by-compound way, with the Thai Food and Drug Administration (Thai FDA) and Ministry of Public Health...
South Korea
RestrictedSouth Korea restricts peptide products through the Ministry of Food and Drug Safety (MFDS), which classifies legitimate peptide drugs as prescription...
Singapore
RestrictedPeptides are restricted in Singapore rather than freely legal or outright criminalized for the individual user: Singapore's Health Sciences Authority (HSA)...
Indonesia
Gray AreaPeptides in Indonesia are not covered by a single, peptide-specific law; instead they fall under Indonesia's general medicines framework administered by BPOM...
Vietnam
Gray AreaPeptides are in a regulatory gray area in Vietnam because no publicly verifiable, Vietnam-specific law or Ministry of Health circular naming BPC-157, TB-500,...
Philippines
Gray AreaPeptides are in a legally gray zone in the Philippines because there is no peptide-specific statute; instead, any drug product (including peptides marketed for...
Africa
South Africa
RestrictedPeptides are restricted in South Africa, not freely legal or outright banned across the board. The South African Health Products Regulatory Authority (SAHPRA)...
South America
Brazil
RestrictedPeptides are restricted in Brazil, with the national health regulator ANVISA drawing a sharp line between a small number of registered, prescription-only...
Argentina
RestrictedPeptides are restricted in Argentina: only specific peptide-based drugs formally registered with ANMAT (such as the GLP-1 medicine semaglutide, sold as...
Colombia
RestrictedPeptides are restricted in Colombia rather than freely legal or outright banned as a class: the national medicines regulator INVIMA (Instituto Nacional de...
Middle East
United Arab Emirates
RestrictedPeptides are restricted in the United Arab Emirates: they are not scheduled as narcotics, but selling or marketing them for human use without MoHAP/EDE drug...
Israel
Gray AreaPeptides are in a legal gray zone in Israel: there is no peptide-specific law naming BPC-157, TB-500, or similar research peptides, so their status is inferred...
Saudi Arabia
RestrictedPeptides in Saudi Arabia are restricted rather than freely available: the Saudi Food and Drug Authority (SFDA) treats unapproved 'research peptides' as...
Turkey
RestrictedPeptides are restricted, not freely legal, in Turkey. Turkey's national medicines regulator, the Türkiye İlaç ve Tıbbi Cihaz Kurumu (TİTCK, Turkish...
Understanding Legal Status Categories
Legal
Peptides generally available for purchase without prescription. May still have sales restrictions (no human consumption claims) or import limits.
Restricted
Prescription required or significant regulatory barriers. May be legal with proper authorization. Personal import may be permitted in limited quantities.
Gray Area
Legal status unclear or inconsistently enforced. May be technically legal but with practical limitations. Situation may vary by specific compound.
Prohibited
Explicitly illegal or classified as controlled substance. Possession or import may result in criminal penalties.